Evidence map

ArticleJournal of ovarian research2025

Inflammasome activation contributes to cisplatin resistance in ovarian cancer.

Josiany Carlos de Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41388308